01/07/2025
Now that federal Food and Drug Administration-approved GLP-1 drugs for obesity treatment are in high demand, state Medicaid programs are grappling with whether to cover them both for reasons of equity and to save on future health expenditures. But some researchers question whether the drugs can help save money in the long run. By Stateline
https://rhodeislandcurrent.com/2025/01/07/as-demand-for-weight-loss-drugs-rises-states-grapple-with-medicaid-coverage/